Hypertension and Cardiovascular Trends in India

Q4 Medicine
Ravikanth Garipalli, M. Azam
{"title":"Hypertension and Cardiovascular Trends in India","authors":"Ravikanth Garipalli, M. Azam","doi":"10.15713/ins.johtn.0163","DOIUrl":null,"url":null,"abstract":"Cardiovascular diseases (CVDs) cause most of the death worldwide. Hypertension (HTN) leads to 57% of cerebrovascular accidents and 24% of all coronary artery disease-deaths in India.[1] According to the World Health Organisation, HTN is one of the leading causes of premature deaths around the globe�[2] The prevalence of CVD is increasing in alarming proportion in India and it accounts for 30% of all deaths. Increasing incidence of CV risk factors such as hypertension (HTN), diabetes mellitus, tobacco use, and metabolic syndrome leads to increasing CVD in India. Apart from tobacco cessation, control of HTN forms the most important of the various treatment strategies to reduce CV mortality. HTN control is poor in developing countries. The Prospective Urban Rural Epidemiology study reported that control of HTN is about 50% in high-income countries and 10% in lowand lower middle-income countries.[3] Studies have reported better control of HTN rates in the past 50 years from Western Europe and the USA.[4] The National Health and Nutrition Examination Surveys from 1988 to 2008 and 1999 to 2012 have reported that the prevalence of HTN remained static at 30–35% during this period, whereas increasing rates of HTN treatment (from 60% to 75%) and its control (from 53% to 69%) were observed.[5] There is a linear relationship between elevation of blood pressure (BP) and CV risk, as the BP rises above 115/75 mmHg.[6] The Global Burden of Diseases (GBD) 2015 analysis reveals that the estimated mortality rate per year associated with systolic BP (SBP) of at least 110–115 mmHg between 1990 and 2015 has risen from 135�6 to 145�2/100,000 persons�[7] Patel et al� have estimated that a decrease of 2 mmHg SBP in the population can prevent approximately 150,000 strokes and coronary artery disease (CAD) deaths in our country�[8] However, prospective data on HTN trends with respect to prevalence, awareness, and treatment from our country are scarce�","PeriodicalId":38918,"journal":{"name":"Open Hypertension Journal","volume":"41 8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Hypertension Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15713/ins.johtn.0163","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases (CVDs) cause most of the death worldwide. Hypertension (HTN) leads to 57% of cerebrovascular accidents and 24% of all coronary artery disease-deaths in India.[1] According to the World Health Organisation, HTN is one of the leading causes of premature deaths around the globe�[2] The prevalence of CVD is increasing in alarming proportion in India and it accounts for 30% of all deaths. Increasing incidence of CV risk factors such as hypertension (HTN), diabetes mellitus, tobacco use, and metabolic syndrome leads to increasing CVD in India. Apart from tobacco cessation, control of HTN forms the most important of the various treatment strategies to reduce CV mortality. HTN control is poor in developing countries. The Prospective Urban Rural Epidemiology study reported that control of HTN is about 50% in high-income countries and 10% in lowand lower middle-income countries.[3] Studies have reported better control of HTN rates in the past 50 years from Western Europe and the USA.[4] The National Health and Nutrition Examination Surveys from 1988 to 2008 and 1999 to 2012 have reported that the prevalence of HTN remained static at 30–35% during this period, whereas increasing rates of HTN treatment (from 60% to 75%) and its control (from 53% to 69%) were observed.[5] There is a linear relationship between elevation of blood pressure (BP) and CV risk, as the BP rises above 115/75 mmHg.[6] The Global Burden of Diseases (GBD) 2015 analysis reveals that the estimated mortality rate per year associated with systolic BP (SBP) of at least 110–115 mmHg between 1990 and 2015 has risen from 135�6 to 145�2/100,000 persons�[7] Patel et al� have estimated that a decrease of 2 mmHg SBP in the population can prevent approximately 150,000 strokes and coronary artery disease (CAD) deaths in our country�[8] However, prospective data on HTN trends with respect to prevalence, awareness, and treatment from our country are scarce�
印度高血压和心血管疾病趋势
心血管疾病(cvd)是全世界死亡人数最多的原因。高血压(HTN)在印度导致57%的脑血管事故和24%的冠状动脉疾病死亡根据世界卫生组织的数据,HTN是全球过早死亡的主要原因之一。在印度,心血管疾病的患病率正以惊人的比例增长,占所有死亡人数的30%。高血压(HTN)、糖尿病、吸烟和代谢综合征等心血管危险因素的发病率增加导致印度心血管疾病的增加。除戒烟外,控制HTN是降低CV死亡率的各种治疗策略中最重要的。发展中国家对HTN的控制很差。前瞻性城乡流行病学研究报告称,高收入国家HTN的控制率约为50%,低收入和中低收入国家为10%研究表明,在过去的50年里,西欧和美国的HTN发病率得到了较好的控制1988年至2008年和1999年至2012年的全国健康和营养检查调查报告显示,在此期间,HTN的患病率保持在30-35%的稳定水平,而HTN治疗率(从60%增加到75%)和控制率(从53%增加到69%)均有所增加当血压升高至115/75 mmHg以上时,血压升高与心血管风险呈线性关系2015年全球疾病负担(GBD)分析显示,1990年至2015年间,与收缩压(SBP)至少为110-115 mmHg相关的每年估计死亡率已从136.5 /10万人上升至145.5 /10万人。Patel等人估计,在我国,人口中降低2 mmHg的收缩压可预防约15万例中风和冠状动脉疾病(CAD)死亡。而来自我们国家的治疗是稀缺的
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Hypertension Journal
Open Hypertension Journal Medicine-Cardiology and Cardiovascular Medicine
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信